Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PGK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CNGA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NPM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD53 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STRBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OR5L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928132 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
DUOXA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZFP57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOLR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POM121L10P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL41 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUCLG2-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SDC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUMO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYRF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTR9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORD14D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCIN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on